R.A. Hannon

Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230

Richard Eastell, Judith E. Adams, Robert E. Coleman et al. · Journal of Clinical Oncology · 2008 · 407 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of an Aromatase Inhibitor on BMD and Bone Turnover Markers: 2-Year Results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) Trial (18233230)

Richard Eastell, R.A. Hannon, Jack Cuzick et al. · Journal of Bone and Mineral Research · 2006 · 322 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of feeding on bone turnover markers and its impact on biological variability of measurements

J. A. Clowes, R.A. Hannon, T.S Yap et al. · Bone · 2002 · 299 citations

Medicine, Nutrition, Nutritional Sciences +14

Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological Variability

R.A. Hannon, Aubrey Blumsohn, K.E. Naylor et al. · Journal of Bone and Mineral Research · 1998 · 262 citations

Medicine, Biochemistry, Endocrinology +17

Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial

Catherine Van Poznak, R.A. Hannon, John R. Mackey et al. · Journal of Clinical Oncology · 2010 · 225 citations

Medicine, Pharmacology, Pharmacotherapy +17